期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021; 27 (6)
Objective We described our initial experience of a new integrated oncology phamaceutical care practice to enhance the quality of pharmacy service and ......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021; 27 (4)
Objective The objective of this article was to offer practical operational process for pharmacists to successfully conduct integrated pharmaceutical c......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, ; ()
Introduction Nivolumab, a programmed death-1(PD-1) inhibitor antibody, have demonstrated anti-tumor activity for multiple malignancies. Such immune ch......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020; 26 (2)
Apatinib is an orally administered small-molecule vascular endothelial growth factor receptor-2 inhibitor that has demonstrated encouraging anticancer......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020; 26 (8)
Introduction Acute promyelocytic leukemia is an oncologic emergency. The limited cases reported in the literature have led to poor understanding of th......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 0; ()
Aims To establish a simple method to identify chemotherapy-induced liver injury among oncological patients. To evaluate current clinical approach to e......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (6)
When encountering a hypersensitivity reaction to chemotherapy, a dilemma arises whether to continue the current regimen. In our institution, a standar......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (7)
Purpose To test the reliability and validity of the Chinese version of the Cancer Stigma Scale (CASS). Methods After translation, back-translation and......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (7)
Introduction For multiple myeloma patients who respond to primary therapy, autologous hematopoietic stem cell transplant (HSCT) is considered standard......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019; 25 (2)
Many oral anticancer agents are recommended to be given either at least 1 h before or 2 h after a meal, according to the prescribing information. Howe......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018; 24 (6)
Objectives: To model the cost-utility of trastuzumab combined with docetaxel for patients with HER-2 positive metastatic breast cancer (mBC) without p......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (7)
Objectives The aims of the study were to evaluate the external contamination of hazardous drug vials used in Chinese hospitals and to compare environm......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (1)
Introduction Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome characterized by excessive production of inflammatory cytokines a......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (6)
Introduction Camrelizumab is an antibody against programmed death protein 1 (PD-1) and is one of immune checkpoint inhibitors (ICI). ICI may lead to a......
期刊： JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (6)
Introduction At present, the prognosis of HER2-positive advanced gastric cancer is extremely poor, and some patients fail to benefit from first-line H......
